# NALDEBAIN for Postoperative Pain Management in Take Down of Anastomosis

> **NCT03854851** · PHASE4 · UNKNOWN · sponsor: **China Medical University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Naldebain
- **DRUG:** Morpine

## Key facts

- **NCT ID:** NCT03854851
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2019-07-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03854851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03854851, "NALDEBAIN for Postoperative Pain Management in Take Down of Anastomosis". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT03854851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*